CEBPA mutation in acute myeloid leukemia: prognostic impact of bZIP domain mutation
One of the most important prognostic genes for acute myeloid leukemia (AML) is CEPBA, and its mutation (CEBPAmu) is present in nearly 10%–15% of de novo AML cases. CEBPAdm is associated with a favorable prognosis; however, CEBPAsm does not appear to have a better prognosis than CEBPAdm. We reviewed...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Sciendo
2024-10-01
|
| Col·lecció: | Forum of Clinical Oncology |
| Matèries: | |
| Accés en línia: | https://doi.org/10.2478/fco-2023-0037 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|